Cited by 563interferon and immune responsesInflammasome and immune disordersImmunodeficiency and Autoimmune Disorders

Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation

Open access
Zhang, Xianqin, Bogunovic, Dusan, Payelle-Brogard, Béatrice, Francois-Newton, Véronique, Speer, Scott D., Yuan, Chao, Volpi, Stefano, Li, Zhi +37 more·2015·Nature

Abstract

Intracellular ISG15 is an interferon (IFN)-α/β-inducible ubiquitin-like modifier which can covalently bind other proteins in a process called ISGylation; it is an effector of IFN-α/β-dependent antiviral immunity in mice. We previously published a study describing humans with inherited ISG15 deficiency but without unusually severe viral diseases. We showed that these patients were prone to mycobacterial disease and that human ISG15 was non-redundant as an extracellular IFN-γ-inducing molecule. We show here that ISG15-deficient patients also display unanticipated cellular, immunological and clinical signs of enhanced IFN-α/β immunity, reminiscent of the Mendelian autoinflammatory interferonopathies Aicardi-Goutières syndrome and spondyloenchondrodysplasia. We further show that an absence of intracellular ISG15 in the patients' cells prevents the accumulation of USP18, a potent negative regulator of IFN-α/β signalling, resulting in the enhancement and amplification of IFN-α/β responses. Human ISG15, therefore, is not only redundant for antiviral immunity, but is a key negative regulator of IFN-α/β immunity. In humans, intracellular ISG15 is IFN-α/β-inducible not to serve as a substrate for ISGylation-dependent antiviral immunity, but to ensure USP18-dependent regulation of IFN-α/β and prevention of IFN-α/β-dependent autoinflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature13801

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ISG15, an interferon-inducible protein necessary for viral protection in mice, does not have the same critical role in humans.

    “Similarly, ISG15, an interferon-inducible protein necessary for viral protection in mice, does not have the same critical role in humans(48-50).”
  • Soluble TRAIL activates cell death pathways in hepatocytes in response to ethanol consumption and has been implicated in hepatic steatosis and hepatocyte death in ASH.

    “Soluble TRAIL activates cell death pathways in hepatocytes in response to ethanol consumption and has been implicated in hepatic steatosis and hepatocyte death in ASH (49).”

    From The liver as a central "hub" of the immune system: pathophysiological implications (2025) · cites this paper as [49]

    The Methods (Cell lines and reagents) and Extended Data passages concern interferon responses and ISG15-deficient cells, not liver injury. Searches for soluble TRAIL, ethanol, hepatocytes, steatosis, and alcoholic steatohepatitis found no passage in our copy addressing the claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]Jeon YJ Yoo HM Chung CH ISG15and immune diseases Biochim. Biophys. Acta 2010 1802 485 496 20153823 PMC7127291

Cited by

Sorted by citations

Authors
Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S. D., Yuan, C., Volpi, S., Li, Z., Sanal, O., Mansouri, D., Tezcan, I., Rice, G. I., Chen, C., Mansouri, N., Mahdaviani, S. A., Itan, Y., Boisson, B., Okada, S., Zeng, L., Wang, X., Jiang, H., Liu, W., Han, T., Liu, D., Ma, T., Wang, B., Liu, M., Liu, J.-Y., Wang, Q. K., Yalnizoglu, D., Radoshevich, L., Uzé, G., Gros, P., Rozenberg, F., Zhang, S.-Y., Jouanguy, E., Bustamante, J., García-Sastre, A., Abel, L., Lebon, P., Notarangelo, L. D., Crow, Y. J., Boisson-Dupuis, S., Casanova, J.-L., & Pellegrini, S.
Affiliations
  • Huazhong University of Science and Technology (CN)
  • Rockefeller University (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Boston Children's Hospital (US)
  • Centre National de la Recherche Scientifique (FR)
  • Masih Daneshvari Hospital (IR)
  • Manchester Academic Health Science Centre (GB)
  • BGI Group (China) (CN)
  • Hubei Provincial Women and Children's Hospital (CN)
  • Cleveland Clinic (US)
  • Institut Pasteur (FR)
  • McGill University (CA)
  • Université Paris Descartes (FR)
  • Hôpital Necker-Enfants Malades (FR)
  • Inserm (FR)
Corresponding author
Bogunovic, Dusan
Venue
Nature
Published
2014-10-12
Volume
517
Issue
7532
Pages
89-93
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1601709990
Cited by
558
References
31
Citations by year
2026: 45 · 2025: 36 · 2024: 56 · 2023: 57 · 2022: 43 · 2021: 49 · 2020: 57 · 2019: 35 · 2018: 36 · 2017: 58 · 2016: 43 · 2015: 42 · 2014: 1
FWCI
20.31
Type
journal article
Language
en
Update notices
erratum (2015-02-11)
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
  • IRIS (submittedVersion)
  • Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • European Commission (200732, 241779, 2007–2013, FP7 2007-2013, FP7/2007, 223608)
  • Agence Nationale de la Recherche
  • Institut National de la Santé et de la Recherche Médicale
  • Ligue Contre le Cancer
  • Centre National de la Recherche Scientifique
  • Greater Manchester Comprehensive Local Research Network
  • National Institutes of Health (UL1TR000043, FP7/2007-2013)
  • Manchester Biomedical Research Centre
  • Japan Society for the Promotion of Science (25713039, 25670477)
  • National Institute of Allergy and Infectious Diseases (P01AI076210, R01AI035237, P01AI090935, 1PO1AI076210-01A1, U19AI083025, R00AI106942, R37AI095983)
  • National Center for Research Resources
  • National Center for Advancing Translational Sciences
  • FP7 Ideas: European Research Council (309449)
  • CHIST-ERA
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Keywords
ISG15, USP18, type I interferon, autoinflammation, Aicardi-Goutières syndrome, interferonopathies, ISGylation, ubiquitin-like proteins, mycobacterial infection, interferon-gamma
MeSH terms
Adolescent, Alleles, Child, Female, Gene Expression Regulation, Humans, Inflammation, Interferon Type I, Male, Pedigree, Endopeptidases, Ubiquitins, Viruses, Signal Transduction, Cytokines, Intracellular Space, Ubiquitin Thiolesterase, S-Phase Kinase-Associated Proteins, Ubiquitination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review